- Article
Targeted Treatment Options of Recurrent Radioactive Iodine Refractory Hürthle Cell Cancer
- Mehtap Derya Aydemirli,
- Willem Corver,
- Ruben Beuk,
- Paul Roepman,
- Nienke Solleveld-Westerink,
- Tom van Wezel,
- Ellen Kapiteijn and
- Hans Morreau
Objective: To evaluate the efficacy and treatment rationale of Hürthle cell carcinoma (HCC) following a patient with progressive and metastatic HCC. HCC was recently shown to harbor a distinct genetic make-up and the mitogen-activated protein ki...